Rituximab and donor lymphocyte infusions are an effective salvage treatment for B-cell lymphoma relapsing after reduced-intensity allogeneic stem cell transplantation

被引:0
|
作者
Spina, F. [1 ]
Patriarca, F. [2 ]
Farina, L.
Montefusco, V.
Dodero, A.
Carniti, C.
Fanin, R. [2 ]
Corradini, P. [1 ]
机构
[1] Univ Studi Milano, Ist Nazl Tumori, Fondaz IRCCS, Milan, Italy
[2] Azienda Ospedaliero Univ Santa Maria Misericordia, Milan, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S245 / S246
页数:2
相关论文
共 50 条
  • [41] Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma
    Lambert, Jonathan R.
    Bomanji, Jamshed B.
    Peggs, Karl S.
    Thomson, Kirsty J.
    Chakraverty, Ronjon K.
    Fielding, Adele K.
    Kottaridis, Panagiotis D.
    Roughton, Michael
    Morris, Emma C.
    Goldstone, Anthony H.
    Linch, David C.
    Ell, Peter J.
    Mackinnon, Stephen
    BLOOD, 2010, 115 (14) : 2763 - 2768
  • [42] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    A. Sureda
    N. Schmitz
    Annals of Hematology, 2003, 82 : 1 - 13
  • [43] Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantation
    Orti, Guillermo
    Garcia-Cadenas, Irene
    Lopez-Corral, Lucia
    Perez, Ariadna
    Jose Jimenez, Maria
    Sanchez-Ortega, Isabel
    Alonso, Laura
    Sisinni, Luisa
    Fox, Laura
    Villacampa, Guillermo
    Badell, Isabel
    Diaz de Heredia, Cristina
    Parody, Rocio
    Ferra, Christelle
    Solano, Carlos
    Caballero, Dolores
    Martino, Rodrigo
    Querol, Sergi
    Valcarcel, David
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1133 - 1137
  • [44] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    T Schroeder
    A Czibere
    U Platzbecker
    G Bug
    L Uharek
    T Luft
    A Giagounidis
    F Zohren
    I Bruns
    C Wolschke
    K Rieger
    R Fenk
    U Germing
    R Haas
    N Kröger
    G Kobbe
    Leukemia, 2013, 27 : 1229 - 1235
  • [45] Salvage therapy with bortezomib for advanced multiple myeloma after reduced-intensity conditioning allogeneic stem cell transplantation
    El Cheikh, J.
    Stoppa, A. M.
    Aurran, T.
    Rey, J.
    Bouabdallah, R.
    Vey, N.
    Coso, D.
    Ivanov, V.
    Charbonnier, A.
    Faucher, C.
    Schiano De Collela, J. M.
    Gastaut, J. A.
    Blaise, D.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S154 - S154
  • [46] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    Schroeder, T.
    Czibere, A.
    Platzbecker, U.
    Bug, G.
    Uharek, L.
    Luft, T.
    Giagounidis, A.
    Zohren, F.
    Bruns, I.
    Wolschke, C.
    Rieger, K.
    Fenk, R.
    Germing, U.
    Haas, R.
    Kroeger, N.
    Kobbe, G.
    LEUKEMIA, 2013, 27 (06) : 1229 - 1235
  • [47] Recombinant erythropoietin after reduced-intensity conditioning for allogeneic stem cell transplantation
    Blaise, D
    Ivanov, V
    Bilger, K
    Faucher, C
    Mohty, M
    Ladaique, P
    Sainty, D
    Chabannon, C
    Vey, N
    Maraninchi, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S327 - S328
  • [48] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    Sureda, A
    Schmitz, N
    ANNALS OF HEMATOLOGY, 2003, 82 (01) : 1 - 13
  • [49] Reduced-intensity conditioning allogeneic stem cell transplantation in malignant lymphoma: current status
    Le Zhang
    Yi-Zhuo Zhang
    Cancer Biology & Medicine, 2013, (01) : 1 - 9
  • [50] Neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation
    Barba, P.
    Pinana, J. L.
    Valcarcel, D.
    Martino, R.
    Sureda, A.
    Delgado, J.
    Briones, J.
    Brunet, S.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S72 - S73